233 related articles for article (PubMed ID: 33722513)
1. Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature.
Kinney RE; Khalil M
Clin Colorectal Cancer; 2021 Jun; 20(2):e109-e112. PubMed ID: 33722513
[No Abstract] [Full Text] [Related]
2. Immunotherapy After Immunotherapy: Response Rescue in a Patient With Microsatellite Instability-high Colorectal Cancer Post-Pembrolizumab.
Das S; Allen A; Berlin J
Clin Colorectal Cancer; 2020 Jun; 19(2):137-140. PubMed ID: 32146081
[TBL] [Abstract][Full Text] [Related]
3. Current status and perspectives of immune checkpoint inhibitors for colorectal cancer.
Hirano H; Takashima A; Hamaguchi T; Shida D; Kanemitsu Y;
Jpn J Clin Oncol; 2021 Jan; 51(1):10-19. PubMed ID: 33205813
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitor therapy in neoadjuvant and adjuvant treatment for cancer: A paradigm shift in the treatment of resectable gastrointestinal cancer 3)A paradigm shift in the treatment of colorectal cancer.
Oshima K; Yamazaki K
Int J Clin Oncol; 2023 Nov; 28(11):1442-1450. PubMed ID: 37668816
[TBL] [Abstract][Full Text] [Related]
5. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review of Neoadjuvant Immunotherapy for Mismatch Repair Deficient Locally Advanced Colon Cancer: An Emerging Strategy.
Loria A; Ammann AM; Olowokure OO; Paquette IM; Justiniano CF
Dis Colon Rectum; 2024 Jun; 67(6):762-771. PubMed ID: 38479009
[TBL] [Abstract][Full Text] [Related]
7. [Organ preservation in locally advanced colorectal cancer with microsatellite instability-high after immunotherapy].
Hong ZG; Xiao BY; Ding PR
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):353-358. PubMed ID: 38644240
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for the treatment of colorectal cancer.
Lumish MA; Cercek A
J Surg Oncol; 2021 Mar; 123(3):760-774. PubMed ID: 33595891
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer.
Greco L; Rubbino F; Dal Buono A; Laghi L
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
[TBL] [Abstract][Full Text] [Related]
10. Current advancements and future perspectives of immunotherapy in colorectal cancer research.
Kishore C; Bhadra P
Eur J Pharmacol; 2021 Feb; 893():173819. PubMed ID: 33347822
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues.
Sahin IH; Ciombor KK; Diaz LA; Yu J; Kim R
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-12. PubMed ID: 35658496
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair-Deficient Colorectal Cancer.
Xiao BY; Zhang X; Cao TY; Li DD; Jiang W; Kong LH; Tang JH; Han K; Zhang CZ; Mei WJ; Xiao J; Pan ZZ; Li YF; Zhang XS; Ding PR
J Natl Compr Canc Netw; 2023 Jan; 21(1):60-66.e5. PubMed ID: 36630898
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside.
Lizardo DY; Kuang C; Hao S; Yu J; Huang Y; Zhang L
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188447. PubMed ID: 33035640
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy Progress in Mismatch Repair-Deficient Colorectal Cancer and Future Therapeutic Challenges.
Link JT; Overman MJ
Cancer J; 2016; 22(3):190-5. PubMed ID: 27341597
[TBL] [Abstract][Full Text] [Related]
15. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
Kothari A; White MG; Peacock O; Kaur H; Palmquist SM; You N; Taggart M; Salem U; Overman M; Kopetz S; Chang GJ
Br J Surg; 2022 May; 109(6):489-492. PubMed ID: 35576377
[No Abstract] [Full Text] [Related]
16. Immunotherapy in Colorectal Cancer - Finding the Achilles' Heel.
Park R; Saeed A
NEJM Evid; 2024 Jun; 3(6):EVIDra2300353. PubMed ID: 38804784
[TBL] [Abstract][Full Text] [Related]
17. Designing Trials for Neoadjuvant Immune Checkpoint Inhibition in Microsatellite Instability-High Localized Colorectal Cancer.
André T; Cohen R
JCO Oncol Pract; 2023 May; 19(5):261-262. PubMed ID: 37011336
[No Abstract] [Full Text] [Related]
18. Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies.
Han YJ; Shao CY; Yao Y; Zhang Z; Fang MZ; Gong T; Zhang YJ; Li M
Postgrad Med J; 2024 May; 100(1184):373-381. PubMed ID: 38211949
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
Zhang Z; Cheng S; Gong J; Lu M; Zhou J; Zhang X; Li J; Shen L; Peng Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e33-e39. PubMed ID: 32732092
[TBL] [Abstract][Full Text] [Related]
20. Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches.
Tan E; Sahin IH
Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):735-742. PubMed ID: 33539189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
